Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
MedComm · 2024-06 · 5 (6)
DOI: 10.1002/mco2.564 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 28.05.2024. Verfasst von Hao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery The Second Affiliated Hospital, Chongqing Medical University Chongqing China. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Currently, tumor treatment modalities such as immunotherapy and targeted therapy have more stringent requirements for obtaining tumor growth information and require more accurate and easy‐to‐operate tumor information detection methods. Compared with traditional tissue biopsy, liquid biopsy is a novel, minimally invasive, real‐time detection tool for detecting information directly or indirectly released by tumors in human body fluids, which is more suitable for the requirements of new tumor treatment modalities. Liquid biopsy has not been widely used in clinical practice, and there are fewer reviews of related clinical applications. This review summarizes the clinical applications of liquid biopsy components (e.g., circulating tumor cells, circulating tumor DNA, extracellular vesicles, etc.) in tumorigenesis and progression. This includes the development process and detection techniques of liquid biopsies, early screening of tumors, tumor growth detection, and guiding therapeutic strategies (liquid biopsy‐based personalized medicine and prediction of treatment response). Finally, the current challenges and future directions for clinical applications of liquid biopsy are proposed. In sum, this review will inspire more researchers to use liquid biopsy technology to promote the realization of individualized therapy, improve the efficacy of tumor therapy, and provide better therapeutic options for tumor patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery The Second Affiliated Hospital, Chongqing Medical University Chongqing China.
- Department of Psychiatry The School of Clinical Medicine, Hunan University of Chinese Medicine Changsha China.
- Department of Psychiatry Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province) Changsha China.
- Health Management Center The Second Affiliated Hospital, Chongqing Medical University Chongqing China.
- Department of Neurosurgery Fengdu People's Hospital, Chongqing Chongqing China.
- College of Life Science and Technology Huazhong University of Science and Technology Wuhan China.
Zitieren
APA
Wang, H., Zhang, Y., Zhang, H., Cao, H., Mao, J., Chen, X., Wang, L., Zhang, N., Luo, P., Xue, J., Qi, X., Dong, X., Liu, G., & Cheng, Q. (2024). Liquid biopsy for human cancer: cancer screening, monitoring, and treatment. MedComm, 5(6). https://doi.org/10.1002/mco2.564
Vancouver
Wang H, Zhang Y, Zhang H, Cao H, Mao J, Chen X, et al. Liquid biopsy for human cancer: cancer screening, monitoring, and treatment. MedComm. 2024;5(6). doi:10.1002/mco2.564
BibTeX
@article{Wang2024,
author = {Wang, Hao and Zhang, Yi and Zhang, Hao and Cao, Hui and Mao, Jinning and Chen, Xinxin and Wang, Liangchi and Zhang, Nan and Luo, Peng and Xue, Ji and Qi, Xiaoya and Dong, Xiancheng and Liu, Guodong and Cheng, Quan},
title = {Liquid biopsy for human cancer: cancer screening, monitoring, and treatment},
journal = {MedComm},
year = {2024},
volume = {5},
number = {6},
doi = {10.1002/mco2.564}
}
EUVIMED